Bicara Therapeutics (BCAX) Interest & Investment Income (2023 - 2026)
Bicara Therapeutics (BCAX) posted Interest & Investment Income of $4.58 million for Q2 2026, down 2.3% from $4.68 million a year earlier but up 12.1% from the prior quarter.
Powered by 
Analysis
Bicara Therapeutics (BCAX) Interest & Investment Income (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Bicara Therapeutics was $16.83 million, down 10.0% year-over-year; for FY2025, it was $17.87 million, up 22.6% from FY2024.
- In prior years, Bicara Therapeutics' Interest & Investment Income was $14.58 million in FY2024 and $1.31 million in FY2023.
- Quarterly Interest & Investment Income has run from a low of $13,000 in Q3 2023 to a high of $5.87 million in Q4 2024 over five years.
- On a year-over-year basis, Interest & Investment Income has declined in each of the last three quarters, with growth averaging 68.9% over the last seven quarters.
- According to Business Quant data, Interest & Investment Income for the three prior quarters was $4.08 million (Q1 2026), $3.79 million (Q4 2025) and $4.39 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Bicara Therapeutics | 1.16 Bn | 1.16 Bn | - | 4.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.58 Mn |
| Mar 31, 2026 | 4.08 Mn |
| Dec 31, 2025 | 3.79 Mn |
| Sep 30, 2025 | 4.39 Mn |
| Jun 30, 2025 | 4.68 Mn |
| Mar 31, 2025 | 5.01 Mn |
| Dec 31, 2024 | 5.87 Mn |
| Sep 30, 2024 | 3.15 Mn |
| Jun 30, 2024 | 2.70 Mn |
| Mar 31, 2024 | 2.87 Mn |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 13,000.00 |
API Access
Bicara Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=BCAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "BCAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=BCAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();